Profile
Marissa Watson worked as the President, CEO, Secretary, Treasurer & Director at Neurotrope, Inc. from 2012 to 2013.
Former positions of Marissa Watson
| Companies | Position | End |
|---|---|---|
| NEUROTROPE, INC. | Director of Finance/CFO | 2013-06-19 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Neurotrope, Inc.
 Neurotrope, Inc. Pharmaceuticals: MajorHealth Technology Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Marissa Watson
